Is SOLV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.

SOLV (Solventum Corporation) Stock Analysis - Financials

Solventum Corporation (SOLV) is a publicly traded Healthcare sector company. As of October 19, 2026, SOLV trades at $85.07 with a market cap of $14.61B and a P/E ratio of 9.83. SOLV moved -0.89% today. Year to date, SOLV is +7.63%; over the trailing twelve months it is +17.86%. Its 52-week range spans $60.70 to $94.16. Analyst consensus is buy with an average price target of $98.50. Rallies surfaces SOLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SOLV's key financials?

SOLV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SOLV recently traded at $85.07. Market cap is $14.61B. P/E ratio is 9.83. Revenue is $8.32B.

SOLV Key Metrics

Key financial metrics for SOLV
Metric	Value
Price	$85.07
Market Cap	$14.61B
P/E Ratio	9.83
EPS	$8.94
Dividend Yield	0.00%
52-Week High	$94.16
52-Week Low	$60.70
Volume	588.93K
Avg Volume	0
Revenue (TTM)	$8.32B
Net Income	$1.56B
Gross Margin	53.47%

SOLV Analyst Consensus

10 analysts cover SOLV: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $98.50.

Common questions about SOLV

What are SOLV's key financials?: SOLV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SOLV recently traded at $85.07. Market cap is $14.61B. P/E ratio is 9.83. Revenue is $8.32B.
Is SOLV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.